Coblopasvir
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Coblopasvir
Description:
Coblopasvir (KW136, KW-136) is a novel HCV NS5A inhibitor under development for treatment of HCV infection.Stability:
≥ 2 yearsPurity:
>98% (HPLC)Weight:
782.899Molecular Formula:
C41H50N8O8Notes:
Research use only, not for human use.Receptor:
HCVCAS Number:
1312608-46-0
